Elham Mohit

Rational design, expression and refolding of a novel bispecific antibody to simultaneously target VEGF-A and Ang-2 for inhibition of angiogenesis

Elahe Pishgahzadeh, Ladan Mafakher, Sara Dabirian, Hossein Vahidi et autres

ir (code pays fourni par la source)

Immunotherapy Treatment of Colorectal Cancer and Lung Metastasis with Genetically Modified Outer Membrane Vesicles Delivering Poly-Neoepitopes in a Mouse Model

Elham Sharif, Leila Nematollahi, Elham Mohit

ir (code pays fourni par la source)

In Silico Analysis of Tat Exons to Increase the Efficacy of a Nef-Tat-based HIV-1 Vaccine Candidate

Leila Sadeghi, Fatemeh Heidarnejad, Azam Bolhassani, Elham Mohit et autres

Background: The global human immunodeficiency virus HIV/AIDS pandemic persists without complete eradication. Developing a safe and effective vaccine remains the most promising approach, but ongoing clinical trials have been unsuccessful due to the vaccines' inability to stimulate robust immunity. Objectives: The present …

ir (code pays fourni par la source)

A Narrative Review on Efficacy of Cell‐ and Tissue‐Based Therapies for Diabetic Foot Ulcer

Behnaz Niroomand, Ibrahim Mohammadzadeh, Maryam Tabarzad, Elham Mohit

Abstract Diabetic foot ulcers (DFUs) are complex, making conventional treatments challenging in restoring skin tissue. Stem cell therapy (SCT) and skin replacement therapy (SRT) offer promising solutions by addressing prolonged inflammation, impaired cell proliferation, and reduced extracellular support. Here, based on the …

ir (code pays fourni par la source)

Bioengineered ClearColi™-derived outer membrane vesicles displaying CT26 neoepitopes as potent vaccine adjuvants against colon carcinoma in a preventive mouse model

Elham Sharif, Taranom Mobasheri, Elham Mohit

ir, cz (code pays fourni par la source)

Recombinant ClearColi™-derived outer membrane vesicles as an effective carrier for development of neoepitope-based vaccine candidate against colon carcinoma

Elham Sharif, Navid Nezafat, Elham Mohit

ir (code pays fourni par la source)

In Silico Design of CT26 Polytope and its Surface Display by ClearColi™-Derived Outer Membrane Vesicles as a Cancer Vaccine Candidate Against Colon Carcinoma

Elham Sharif, Navid Nezafat, Fatemeh Maghsood Ahmadi, Elham Mohit

ir (code pays fourni par la source)

Engineered ClearColi™-derived outer membrane vesicles as functional carriers for development of HIV-1 therapeutic vaccine candidate

Leila Sadeghi, Azam Bolhassani, Elham Mohit, Kazem Baesi et autres

ir (code pays fourni par la source)

Preparation, Characterization, and Radiolabeling of Anti‐HER2 scFv With Technetium Tricarbonyl and Stability Studies

Negar Bozorgchami, Maryam Ahmadzadeh, Dara Hatamabadi, Abdolreza Yazdani et autres

ABSTRACT Breast cancer is the most common diagnosed cancer, and the second cause of cancer death among women, worldwide. HER2 overexpression occurred in approximately 15% to 20% of breast cancers. Invasive biopsy method has been used for detection of HER2 overexpression. HER2‐targeted …

ir (code pays fourni par la source)

Heterologous DNA Prime/Protein Boost Immunization Targeting Nef-Tat Fusion Antigen Induces Potent T-cell Activity and in vitro Anti-SCR HIV-1 Effects

Leila Sadeghi, Azam Bolhassani, Elham Mohit, Kazem Baesi et autres

Background: Heterologous combinations in vaccine design are an effective approach to promote T cell activity and antiviral effects. The goal of this study was to compare the homologous and heterologous regimens targeting the Nef-Tat fusion antigen to develop a human immunodeficiency virus-1 …

ir (code pays fourni par la source)

Functionalized peptide and protein-based nanomaterials for cancer therapy

Maryam Tabarzad, Elham Mohit, Fatemeh Maghsood Ahmadi

ir (code pays fourni par la source)

List of contributors

Ernest C. Agwamba, Samad Ahadian, Fatemeh Maghsood Ahmadi, Roohollah Ahmadian et autres

Nigéria, ir, tr, fr, mx, us, de (code pays fourni par la source)